Skip to main content

SRS 8.2, Ingenuity Pathways Analysis 4.0, IGB, DecisionSite, Ensembl 39, UCSC Genome Browser, GenBank 154.0, COPASI, DogBox Inside, Benchware Notebook 2.1


BioWisdom has released SRS 8.2, the first SRS update since BioWisdom acquired Lion Bioscience's bioinformatics business in April. SRS 8.2 is twice as fast for common indexing and querying tasks as previous versions, according to the company. The new version also offers improved data sharing and a simplified start page. The standard SRS package now includes SRS Relational, which allows users to combine and analyze internally generated databases with the third-party information supplied via SRS.

Ingenuity Systems has launched Ingenuity Pathways Analysis 4.0, which includes enhanced search and reporting capabilities. IPA 4.0 enables users to conduct and save advanced searches for genes, proteins, or biological relationships; create reports on bibliographies of pathway information; and export high-resolution images for publication and presentations. IPA 4.0 also supports the Mac platform in addition to PCs. Ingenuity is offering trials of the software at

Affymetrix has released version 4.38 of IGB (Integrated Genome Browser), an application for visualizing genomes and annotations from multiple data sources, at

Spotfire has released analytic services for its DecisionSite software so that pharmaceutical scientists can visually analyze and interact with data from clinical trials. Features include integration with customer clinical data management and electronic data capture systems, support for SAS files and programs, and guided analyses for quality control and monitoring of clinical data.

Ensembl 39 is available at The release includes new assemblies for mouse, zebrafish, opossum, and Ciona savignyi and other updates.

The Genome Bioinformatics Group at the University of California, Santa Cruz, has released version 4.1 of the Xenopus tropicalis assembly through the UCSC Genome Browser at and a Genome Browser for the v3.4 Rattus norvegicus genome at or

The National Center for Biotechnology Information has released GenBank 154.0 at The release contains 63,412,609,711 base pairs and 58,890,345 entries. Uncompressed, the 154.0 flat files require about 222 GB for the sequence files only. The ASN.1 version requires around 192 GB. NCBI said that a new protein residue abbreviation for the 22nd amino acid, pyrrolysine, will become "legal" in GenBank protein sequences as of release 156.0, in October. "Because several letters are assigned to represent different experimental ambiguities, the only letter still available for use is O (uppercase letter o)," NCBI said. For Blast and other sequence similarity search tools, NCBI said it will map pyrrolysine (O) to unknown (X), as it already does with selenocysteine (U), the 21st encoded amino acid. The 156.0 release will also include the residue abbreviation J for leucine/isoleucine ambiguities in mass spectrometry experiments. "Although this abbreviation has been part of the IUPAC recommendations for some time, it has not previously appeared in protein sequences in the GenBank database," NCBI said.

EML Research and the Virginia Bioinformatics Institute have launched COPASI (Complex Pathway Simulator), a software package that allows users to model, simulate, and analyze biochemical and systems biology networks, at

Unleashed Informatics has launched DogBox Inside, a remotely maintained data warehouse that is installed on the customer's in-house hardware and open to customer audit and compliance requirements. DogBox Inside includes hourly updated gene sequence and molecular interaction data from 18 sources, as well as pre-computed BlastP and RPS-Blast information for all protein sequences in NCBI's NR database. The service is priced at $14,500 per year.

Tripos has released Benchware Notebook 2.1, an update of its enterprise electronic laboratory notebook. The new version includes a new page navigation toolbar and increased support for third-party chemical sketching applications.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.